Folate receptor alpha as a tumor target in epithelial ovarian cancer - Wikidata - wikimedia - TriplyDB

Folate receptor alpha as a tumor target in epithelial ovarian cancer

Folate receptor alpha as a tumor target in epithelial ovarian cancer

http://www.wikidata.org/entity/Q37254805

about

Targeting folate receptor alpha for cancer treatment Profile of farletuzumab and its potential in the treatment of solid tumors A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer Synthetic high-density lipoprotein-like nanoparticles as cancer therapy Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review New perspectives on targeted therapy in ovarian cancer Folate receptor-targeted ultrasonic PFOB nanoparticles: Synthesis, characterization and application in tumor-targeted imaging.Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green.Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.Functional folate receptor alpha is elevated in the blood of ovarian cancer patients.A current review of targeted therapeutics for ovarian cancer.Pathogenesis of ovarian cancer: clues from selected overexpressed genes.Relationship between dietary and supplemental intake of folate, methionine, vitamin B6 and folate receptor alpha expression in ovarian tumors.Rapid and Selective Determination of Folate Receptor α with Sensitive Resonance Rayleigh Scattering Signal.Investigational agents in development for the treatment of ovarian cancer In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB)Pemetrexed disodium in ovarian cancer treatment.Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression.Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse model Immunity and immune suppression in human ovarian cancer.Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) Ligand Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers.Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer Synthesis and evaluation of perfluorooctylbromide nanoparticles modified with a folate receptor for targeting ovarian cancer: in vitro and in vivo experiments.Characterization of the human folate receptor alpha via novel antibody-based probes.Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.Clinical utility of targeted treatments in the management of epithelial ovarian cancer.Synthetic high-density lipoprotein-like nanoparticles for cancer therapy A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity.Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer.Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.Gold nanorods for target selective SPECT/CT imaging and photothermal therapy in vivo.Development of Follicle-Stimulating Hormone Receptor Binding Probes to Image Ovarian Xenografts.

P2860

Q26744215-FDC5A812-39DF-49C5-908C-B3E6E32A38DA Q26750431-47F6E0A7-990D-4086-9CEB-782F458D5ADE Q26781856-7419504A-55CE-4745-A994-F804EDF15FC8 Q26825009-5A4C77F7-9655-4B73-98B5-0800DB6AFD4C Q26828581-C751B759-F056-4199-9624-B361120EC15B Q28082524-4DE5BDB8-F3B8-4F77-8F60-AA3AAEB1B2A3 Q30356285-CE6C749A-8AE8-4B67-9A71-B0DEDABCB484 Q30360668-DCAB7755-3001-4367-8073-E19C1C2F26CC Q30423597-3438ED81-EAED-44A1-BE41-7992012AE645 Q30502897-4E6AA251-FDE4-4189-BD61-2E885A1316B1 Q31169933-2CEF94E3-73F2-4238-9AB6-D86EFDA03A9D Q33484181-BE98EDAB-AF72-4298-99E5-EC82EE1EF730 Q33580998-9187FB2C-C515-493A-AF52-EAB652922424 Q33651139-6230A294-00EC-4DEF-9ACB-B4E496E26B82 Q33765535-1ED97431-A348-40F7-90B2-37355A6684B8 Q33775377-FE4A05E6-EE08-4B9D-8BA6-5E1CB8BAED9A Q33920800-86B9868B-9460-4CDD-90EB-D49DB5B3B9DC Q34073529-01583EBD-E80C-48A7-B17B-74D455F76E25 Q34253505-D886DF40-2FFF-4E51-9A92-F7E728706E00 Q34687073-7193E4F1-C38F-4826-9E9C-FDC63073197B Q34893030-38C802C8-25A7-4F70-909B-95A87A0485AD Q34979610-91DD6457-5DA5-4787-B561-1AFA6DA2170C Q35057527-93820E7C-8168-4470-98D1-4B68391A46D3 Q35138135-20D01D90-F312-4C55-96C5-6EAAE3094372 Q35292124-765C29EC-2BB1-48BC-9719-AA72A48762C9 Q35652998-6658EE4D-2ECC-43B7-BEC5-B80205D67E40 Q35730185-0D60137C-3EF7-46B2-B9A8-EF3D4C20CAAA Q35738875-1E548688-4498-4A0A-8CBB-844F8124EBAD Q35756395-75778022-A90B-4939-BFC8-672570F1B838 Q35764371-493917D9-B32F-443A-9251-D3E31BFCDC3E Q35780797-759CED07-47FC-4FA0-9C0B-33B33DF03F30 Q35837949-2122E5EE-0985-467E-B030-5BC22AF8CAF5 Q35854305-909BA3BD-6746-4116-B6FC-36155B5C9BA8 Q36171268-37F7D44A-6E24-4FC7-AD9E-6B0AD4582931 Q36264073-25B36E32-5B54-429D-B7F8-631D87778BF4 Q36356392-CB50FB3C-6857-4FF5-B1AF-7907CEA287BE Q36361160-55697458-637B-49A2-A476-1A71B728CF07 Q36380927-FCB00EE4-046A-497A-80AC-7836766991CF Q36394209-1CE7A8BC-14AE-4860-880E-7438103EE4BC Q36462856-F9F1A045-4DED-4CFA-8CB1-5590F7F56BF6

P2860

Folate receptor alpha as a tumor target in epithelial ovarian cancer

http://www.wikidata.org/entity/Q37254805

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Folate receptor alpha as a tumor target in epithelial ovarian cancer

@en

Folate receptor alpha as a tumor target in epithelial ovarian cancer.

@nl

type

label

Folate receptor alpha as a tumor target in epithelial ovarian cancer

@en

Folate receptor alpha as a tumor target in epithelial ovarian cancer.

@nl

prefLabel

Folate receptor alpha as a tumor target in epithelial ovarian cancer

@en

Folate receptor alpha as a tumor target in epithelial ovarian cancer.

@nl

P1433

Q37254805-1E8D25EB-B07F-4D6C-9929-88AE00965A5C

P1476

Q37254805-60B0FF59-43C7-4020-988D-9313E4729D0D

P2093

Q37254805-172CC6CE-6E0B-46AE-9100-0DDE3625DFF5

Q37254805-2BFFD3B1-B3EE-44A8-9150-A6A6191E2E59

Q37254805-5AFDECE6-6246-4615-8D52-C14BFB491D44

Q37254805-97FB9675-58A9-4AA8-BF92-78CE88DB4C3F

Q37254805-987461CB-8747-4271-89F3-63EA9627EBD9

Q37254805-C1CEA128-E769-44D4-BFCB-1C81DA426D99

Q37254805-D1986682-3DE1-4E96-B080-7B7B33830743

P2860

Q37254805-03896C8C-53DE-4C1D-9D2A-B7986A1B58EF

Q37254805-07CB7937-07DA-41BC-9CF6-543CD4508395

Q37254805-0B2FB3FE-BC6E-42D1-9B4F-C21426D3D656

Q37254805-0D5884C3-9B4B-45F0-A567-13BBC70A26D5

Q37254805-0DC2A5C8-485B-4A56-9A0A-4905E90D86CB

Q37254805-11E9DC2A-62D6-4499-8B92-62084C7F7174

Q37254805-121EDB8E-9D7E-4FE8-802A-C45CB7C91093

Q37254805-16E9C1C1-ECB1-410B-922D-8E311F9B456A

Q37254805-1B268C0A-D2DB-4D8F-8508-49235C86C122

Q37254805-26118009-E9DC-4024-BC84-2B21B940CB62

P304

Q37254805-3948C914-52A1-46C7-AD64-67C8F90CC777

P31

Q37254805-198612C4-3876-4B94-9C71-05BCEB2CDD61

P356

Q37254805-295CACE7-EB14-4AB8-B8DF-6EC5BE7E9069

P407

Q37254805-226D5772-B168-4B53-B2BD-CE8714C78140

P433

Q37254805-07699C59-C7D7-4015-9626-436A91ED663E

P478

Q37254805-9A7B6015-3349-4000-83DF-ABDB57350AA5

P577

Q37254805-6A0910B8-D9A2-429F-A2F7-561376337CA7

P5875

Q37254805-EFAE2BDF-93DC-45E6-8335-2B6BF57C0765

P698

Q37254805-56A7CC29-9475-4428-BE10-B6D8D02532BA

P921

Q37254805-76EFDC37-B989-4226-BC32-1ADE263B8464

P932

Q37254805-4342FD1F-AB2A-4079-A5DE-DD5D85F537AF

P356

J.YGYNO.2007.11.020

P1433

Gynecologic Oncology

P1476

Folate receptor alpha as a tumor target in epithelial ovarian cancer

@en

P2093

Ann L Oberg

http://www.w3.org/2001/XMLSchema#string

Gary L Keeney

http://www.w3.org/2001/XMLSchema#string

Keith L Knutson

http://www.w3.org/2001/XMLSchema#string

Kimberly R Kalli

http://www.w3.org/2001/XMLSchema#string

Lynn C Hartmann

http://www.w3.org/2001/XMLSchema#string

Philip S Low

http://www.w3.org/2001/XMLSchema#string

Teresa J H Christianson

http://www.w3.org/2001/XMLSchema#string

P2860

Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity

Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis

Folate-binding protein is a marker for ovarian cancer

Targeting therapeutic and imaging agents to folate receptor positive tumors.

Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis.

Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications.

Cancer of the ovary.

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.

P304

619-626

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2007.11.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5628333

http://www.w3.org/2001/XMLSchema#string

P698

18222534

http://www.w3.org/2001/XMLSchema#string

P921

P932

2707764

http://www.w3.org/2001/XMLSchema#string